Nippon Kayaku withdraws Spanidin MAA

EMEA said Nippon Kayaku (Tokyo, Japan) withdrew an MAA for Spanidin gusperimus to treat refractory Wegener's granulomatosis, a disease in which the blood vessels are inflamed. Nippon Kayaku told the a...